Live Breaking News & Updates on Vp Clinical Sciences At Glenmark Pharmaceuticals

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management
Atriva Therapeutics Announces Changes to Management
13.04.2021 / 09:30
Atriva Therapeutics Announces Changes to Management
- Olaf Althaus appointed Chief Financial Officer
- Stephan Stenglein, M.D., recently joined as Chief Medical Officer
- Proven track record and 20+ years of experience in their respective fields of expertise
Tübingen (Germany), April 13, 2021 - Atriva Therapeutics GmbH, a biopharmaceutical company that is pioneering the development of host-targeting antiviral therapies, today announced two changes to its management team. Olaf Althaus was appointed Chief Financial Officer, effective May 2020, while Stephan Stenglein, M.D., was named Chief Medical Officer, effective February 2021. ....

Frankfurt Am Main , Nordrhein Westfalen , City Of , United Kingdom , Eva Bauer Raimund Gabriel , Olaf Althaus , Stephan Stenglein , Kostenloser Wertpapierhandel , Gernot Rohde , Aeterna Zentaris Gmb , Rainer Lichtenberger , Mc Services , Global Program , Global Program Clinical Head , Centre Clinical Trial To Evaluate The Safety , Distribution Services , Stage Development Respiratory At Astrazeneca , Shire Plc , Goethe University Hospital , Karlsruhe University Diplom Wirtschaftsingenieurwesen , Vp Clinical Sciences At Glenmark Pharmaceuticals , Atriva Therapeutics Gmbh , Therapeutics Announces Changes , Chief Financial , Chief Medical , Therapeutics Gmbh ,